Cingulate signs agreement to market its first drug candidate
March 13, 2023 at 08:49 AM EDT
The firm's first drug candidate will provide a once-daily treatment for ADHD.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|